Literature DB >> 9868666

Seroprevalence of human granulocytic ehrlichiosis among permanent residents of northwestern Wisconsin.

J S Bakken1, P Goellner, M Van Etten, D Z Boyle, O L Swonger, S Mattson, J Krueth, R L Tilden, K Asanovich, J Walls, J S Dumler.   

Abstract

Four-hundred seventy-five permanent residents of Wisconsin were tested for antibodies to the agent of human granulocytic ehrlichiosis (HGE) by indirect immunofluorescent antibody (IFA) testing with Ehrlichia equi as antigen marker. Each resident completed a standard survey questionnaire about outdoor activities, animal and tick exposure, and any febrile illness during the preceding 12 months. Seventy-one serum samples (14.9%) contained E. equi antibodies. The mean IFA titer for seropositive residents was 250 (range, 80-10,240). Seropositive residents were older than seronegative ones (62 vs. 56 years; P = .019). None of the seropositive residents had a history suggestive of ehrlichiosis. There was no association between the IFA test outcome and specific demographic variables or history of tick bites. HGE appears to be a common subclinical or mild infection among residents in northwestern Wisconsin.

Entities:  

Mesh:

Year:  1998        PMID: 9868666     DOI: 10.1086/515048

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  33 in total

1.  Human granulocytic anaplasmosis in the United States from 2008 to 2012: a summary of national surveillance data.

Authors:  F Scott Dahlgren; Kristen Nichols Heitman; Naomi A Drexler; Robert F Massung; Casey Barton Behravesh
Journal:  Am J Trop Med Hyg       Date:  2015-04-13       Impact factor: 2.345

2.  Development of a Sensitive and Rapid Recombinase Polymerase Amplification Assay for Detection of Anaplasma phagocytophilum.

Authors:  Le Jiang; Philip Ching; Chien-Chung Chao; J Stephen Dumler; Wei-Mei Ching
Journal:  J Clin Microbiol       Date:  2020-04-23       Impact factor: 5.948

Review 3.  Mechanisms of obligatory intracellular infection with Anaplasma phagocytophilum.

Authors:  Yasuko Rikihisa
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

4.  Increasing incidence of Ehrlichia chaffeensis and Anaplasma phagocytophilum in the United States, 2000-2007.

Authors:  F Scott Dahlgren; Eric J Mandel; John W Krebs; Robert F Massung; Jennifer H McQuiston
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

Review 5.  Human granulocytic anaplasmosis.

Authors:  Johan S Bakken; J Stephen Dumler
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

6.  Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts.

Authors:  Ana A Weil; Elinor L Baron; Catherine M Brown; Mark S Drapkin
Journal:  Mayo Clin Proc       Date:  2012-03       Impact factor: 7.616

7.  Epidemiology of ehrlichiosis and anaplasmosis among American Indians in the United States, 2000-2007.

Authors:  Arianne M Folkema; Robert C Holman; F Scott Dahlgren; James E Cheek; Jennifer H McQuiston
Journal:  Am J Trop Med Hyg       Date:  2012-07-23       Impact factor: 2.345

8.  Analysis of genetic identity of North American Anaplasma phagocytophilum strains by pulsed-field gel electrophoresis.

Authors:  J S Dumler; K M Asanovich; J S Bakken
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

9.  Outcomes of treated human granulocytic ehrlichiosis cases.

Authors:  Alan H Ramsey; Edward A Belongia; Craig M Gale; Jeffrey P Davis
Journal:  Emerg Infect Dis       Date:  2002-04       Impact factor: 6.883

10.  Predicting the risk of Lyme disease: habitat suitability for Ixodes scapularis in the north central United States.

Authors:  Marta Guerra; Edward Walker; Carl Jones; Susan Paskewitz; M Roberto Cortinas; Ashley Stancil; Louisa Beck; Matthew Bobo; Uriel Kitron
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.